Marina Biotech, Inc., is a pharmaceutical and biotechnology company. The Company is focused on the discovery, development and commercialization of nucleic acid-based therapies to treat orphan diseases. The Company has acquired and in-licensed and further developed nucleic acid chemistry and delivery-related technologies to form an integrated drug discovery platform. The Company’s Nucleic acid-based therapeutics targets two types of RNA: coding RNA and non-coding RNA. The Company continues to seek to establish collaborations and strategic partnerships with pharmaceutical and biotechnology companies. The Company is engaged in therapeutic and scientific of delivery of nucleic acid-based therapeutics in the treatment of human disease including orphan diseases.